Raymond James Financial
BNTX icon

Raymond James Financial’s BioNTech BNTX Stock Holding History

Raymond James Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Buy
8,227
+1,233
+18% +$116K ﹤0.01% 4190
2026
Q1 		$622K Buy
6,994
+694
+11% +$71.3K ﹤0.01% 4201
2025
Q4 		$600K Buy
6,300
+240
+4% +$24.2K ﹤0.01% 4138
2025
Q3 		$598K Sell
6,060
-586
-9% -$62.7K ﹤0.01% 4006
2025
Q2 		$708K Sell
6,646
-3,935
-37% -$397K ﹤0.01% 3790
2025
Q1 		$963K Buy
10,581
+5,459
+107% +$611K ﹤0.01% 3522
2024
Q4 		$584K Buy
+5,122
New +$585K ﹤0.01% 3805

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Raymond James Financial's BNTX Position: Q2 2026 in Review

Raymond James Financial increased its BioNTech (BNTX) stake by 18% in Q2 2026, buying an estimated $116K and bringing the position to 8,227 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Raymond James Financial first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $963K in Q1 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Raymond James Financial held 8,227 shares of BioNTech worth $766K as of Q2 2026.
  • Raymond James Financial bought 1,233 BioNTech shares in Q2 2026, an estimated $116K.
  • BioNTech made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4190 holding.
  • Raymond James Financial first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's BioNTech position peaked at $963K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.